Second-Line Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A 12-Year Study of Annual Eradication Rates

Background: Bismuth-containing quadruple therapy (BQT) consisting of a proton-pump inhibitor (PPI), bismuth, metronidazole and tetracycline is recommended as a second-line treatment for Helicobacter pylori (H. pylori) infection when PPI-based standard triple therapy (STT) consisting of a PPI, amoxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Kiwon, Cho, Min-Jae, Oh, Jung-Hwan, Lim, Chul-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347213/
https://www.ncbi.nlm.nih.gov/pubmed/34362057
http://dx.doi.org/10.3390/jcm10153273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347213/
https://www.ncbi.nlm.nih.gov/pubmed/34362057
http://dx.doi.org/10.3390/jcm10153273

Ejemplares similares